Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury. (Q55054604)

16 June 2018

title

Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury. (English)

1 reference

16 June 2018

1 reference

3

Masashi Mizuno

1 reference

16 June 2018

Yasuhiko Ito

2

Yasuhiko Ito

1 reference

16 June 2018

Seiichi Matsuo

13

Seiichi Matsuo

1 reference

16 June 2018

Shoichi Maruyama

11

Shoichi Maruyama

1 reference

16 June 2018

Yasuhiro Suzuki

4

Yasuhiro Suzuki

1 reference

16 June 2018

Enyu Imai

12

Enyu Imai

1 reference

16 June 2018

Fumiko Sakata

6

Fumiko Sakata

1 reference

16 June 2018

Yoshifumi Takei

14

Yoshifumi Takei

1 reference

16 June 2018

author name string

Takeshi Terabayashi

1

1 reference

16 June 2018

Hiroshi Kinashi

5

1 reference

16 June 2018

Takako Tomita

7

1 reference

16 June 2018

Daiki Iguchi

8

1 reference

16 June 2018

Mitsuhiro Tawada

9

1 reference

16 June 2018

Ryosuke Nishio

10

1 reference

16 June 2018

publication date

29 June 2015

1 reference

16 June 2018

published in

Laboratory Investigation

1 reference

16 June 2018

volume

95

1 reference

16 June 2018

page(s)

1029-1043

1 reference

16 June 2018

issue

9

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.2015.87

exact match

0 references

cites work

Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Epigallocatechin gallate suppresses peritoneal fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Pharmacokinetics of icodextrin in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Lymphangiogenesis: Molecular mechanisms and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Lymphangiogenesis in development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Recommendations for the use of icodextrin in peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Transforming growth factor-β1 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2015.87

Lymphatic vessels develop during tubulointerstitial fibrosis

21 January 2018

1 reference

12 December 2020

The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis

1 reference

12 December 2020

Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study.

1 reference

12 December 2020

Effective lymphatic absorption rate is not a useful or accurate term to use in the physiology of peritoneal dialysis.

1 reference

12 December 2020

Peritoneal mesothelial cell culture and biology.

1 reference

12 December 2020

Isolation, culture and characterization of human peritoneal mesothelial cells

1 reference

12 December 2020

Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation

1 reference

12 December 2020

Effects of peritoneal rest on peritoneal transport and peritoneal membrane thickening in continuous ambulatory peritoneal dialysis rats

1 reference

12 December 2020

Clinical practice guidelines for peritoneal adequacy, update 2006

1 reference

12 December 2020

Searching for the reasons for drop-out from peritoneal dialysis: a nationwide survey in Japan

1 reference

12 December 2020

The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis

1 reference

12 December 2020

The effective lymphatic absorption rate is an accurate and useful concept in the physiology of peritoneal dialysis

1 reference

12 December 2020

Peritoneal injury by methylglyoxal in peritoneal dialysis

1 reference

12 December 2020

Morphologic changes in the peritoneal membrane of patients with renal disease

1 reference

12 December 2020

Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis

1 reference

12 December 2020

Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis

1 reference

12 December 2020

Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence.

1 reference

12 December 2020

10.1038/LABINVEST.2015.87

Identifiers

DOI

1 reference

16 June 2018

Dimensions Publication ID

0 references

1 reference

16 June 2018